NNPTE
NKTR icon

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Nektar Therapeutics NKTR Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57M Buy
122,767
+441
+0.4% +$32.3K 0.47% 28
2026
Q1 		$8.8M Sell
122,326
-65,786
-35% -$3.75M 0.75% 27
2025
Q4 		$7.95M Buy
188,112
+34,266
+22% +$1.92M 0.71% 27
2025
Q3 		$8.75M Buy
+153,846
New +$5.09M 0.68% 29

Other funds holding NKTR

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's NKTR Position: Q2 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne increased its Nektar Therapeutics (NKTR) stake by 0.36% in Q2 2026, buying an estimated $32.3K and bringing the position to 122,767 shares worth $8.57M. The position accounts for 0.47% of the portfolio, ranked #28.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in NKTR in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.8M in Q1 2026. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held 122,767 shares of Nektar Therapeutics worth $8.57M as of Q2 2026.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne bought 441 Nektar Therapeutics shares in Q2 2026, an estimated $32.3K.
  • Nektar Therapeutics made up 0.47% of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's portfolio in Q2 2026, its #28 holding.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Nektar Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Nektar Therapeutics position peaked at $8.8M in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2026, filed 7 Aug 2026.